BIT 6.67% 3.2¢ biotron limited

Ann: Appointment of International Advisory Board for BIT225, page-107

  1. J8
    14,549 Posts.
    lightbulb Created with Sketch. 822
    No idea.
    I prefer to wait and not guess.

    Meanwhile, Gilead continue the search for strategies including control and cure.

    GS9620 has recently been (July) proven safe and pharmacologically active, for HIV and HBV. And it has already had success with SHIV. Long winded trials are ongoing.

    There is not a huge rush here. MM will be fully up to speed with what is happening across the entire field of cure and/or control programs. Cure strategies are coming along very, very slowly.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $13.79K 424.2K

Buyers (Bids)

No. Vol. Price($)
1 329429 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 100000 1
View Market Depth
Last trade - 15.51pm 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.